Related Experiment Videos
Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical,
A Egge1, K Waterloo, H Sjøholm
1Department of Neurosurgery, University Hospital of Tromsø, Norway.
Neurosurgery
|August 29, 2001
Summary
Hyperdynamic postoperative fluid therapy did not improve outcomes for subarachnoid hemorrhage patients. This approach did not prevent cerebral vasospasm or neurological deficits, and led to more complications.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Subarachnoid hemorrhage (SAH) poses significant risks, including delayed ischemic neurological deficits due to cerebral vasospasm.
- Optimizing fluid management is crucial in SAH patients to prevent complications.
Purpose of the Study:
- To evaluate the efficacy of prophylactic hyperdynamic postoperative fluid therapy in preventing delayed ischemic neurological deficits in SAH patients.
- To compare hypervolemic hypertensive hemodilution with normovolemic fluid therapy.
Main Methods:
- A prospective, randomized controlled study involving 32 SAH patients.
- Two groups: 16 received hyperdynamic therapy, 16 received normovolemic therapy.
- Monitoring included clinical assessments, transcranial Doppler, SPECT, CT scans, and continuous hemodynamic monitoring for at least 12 days.
Main Results:
- No significant differences in cerebral vasospasm between groups, assessed clinically and via transcranial Doppler.
- Single-photon emission computed tomographic (SPECT) scans showed no differences in regional cerebral blood flow.
- One-year follow-up revealed no significant differences in Glasgow Outcome Scale scores, neuropsychological function, or SPECT findings.
Conclusions:
- Prophylactic hyperdynamic postoperative fluid therapy did not demonstrate benefits in preventing vasospasm or improving outcomes in SAH patients.
- The hyperdynamic group experienced higher costs and more frequent complications.
- Current fluid management strategies for SAH require re-evaluation.